The treatment that someone with small cell lung cancer (SCLC) receives can significantly affect their outlook. The most effective SCLC treatments often involve surgery, but not all individuals with ...

Getting a diagnosis of lung cancer can be scary, especially when you don't know what to expect. To help, experts will guide ...

Multidisciplinary evaluation, including thoracic surgical consultation, is crucial for oligometastatic NSCLC patients to optimize treatment strategies. Lung surgery for oligometastatic NSCLC shows ...

Stage 3 lung cancer is considered locally advanced with spread in the region near the site. Survival rates for stage 3 non-small cell lung cancer (NSCLC) range from as high as 36% to as low as 13%, ...

CURE spoke with a thoracic surgeon about the impact of minimally invasive surgery for patients. For patients with lung cancer, advancements such as robotic surgery and video-assisted thoracic surgery ...

CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. Cooler start to August in western Massachusetts The ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...

Small cell lung cancer (SCLC) and other neuroendocrine tumors (NETs) are a group of cancers that originate from neuroendocrine cells, which release hormones into the bloodstream when they receive ...

Lung (pulmonary) sarcoma is a rare type of lung cancer. Most lung cancers start in epithelial cells that line your airways, but pulmonary sarcoma develops in connective tissue or other nonepithelial ...

Regular postsurgical screening is critical for patients with lung cancer, the United States' second most prevalent type of cancer and leading cause of cancer deaths. In cases involving early-stage non ...

Dec. 19 (UPI) --To help surgeons with the exacting task of finding and removing lung cancer cells, and sparing healthy tissue, the Food and Drug Administration has approved a fluorescent imaging agent ...